Investors expect the company to underperform the broader industry, contributing to its low P/S ratio. The company's recent revenue decline could stagnate the share price if the trend continues.
North China Pharmaceutical Company.Ltd's recent share sell-off could be an opportunity. However, the company shows 1 warning sign in investment analysis, potentially not the best stock to buy.
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
North China Pharmaceutical Stock Forum
No comment yet